Facial Plast Surg 2019; 35(03): 248-255
DOI: 10.1055/s-0039-1688846
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diode Laser and Fractional Laser Innovations

Kaete A. Archer
1   Private Practice, Aesthetic Institute of Manhattan for Facial and Plastic Surgery, New York, New York
Paul Carniol
2   Department of Otolaryngology - Head and Neck Surgery, Rutgers New Jersey Medical School, Summit, New Jersey
› Author Affiliations
Further Information

Publication History

Publication Date:
12 June 2019 (online)


Laser technology continues to increase in popularity and expand treatment options for patients with common but challenging skin conditions including facial telangiectasias, facial aging, striae distensae, and acne scars. Facial telangiectasias have been estimated to occur in tens of millions of people worldwide. The 585-nm laser was the first to follow the principle of selective photothermolysis for the treatment of cutaneous vascular lesions, but it caused significant postoperative purpura. Newer diode lasers target superficial and deep telangiectasias without the side effects of the 585-nm laser. Ablative resurfacing was introduced in the 1990s with the carbon dioxide laser to address facial rhytids and photoaging. While effective, the risks and downtime were significant. The newest fractionated nonablative lasers are demonstrating impressive results, with decreased risks and downtime. This new generation of lasers is being used extensively and in unique combinations for facial aging, striae, and acne scars.